PROBEN-C Drug Patent Profile
Which patents cover Proben-c, and what generic alternatives are available?
Proben-c is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in PROBEN-C is colchicine; probenecid. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the colchicine; probenecid profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROBEN-C?
- What are the global sales for PROBEN-C?
- What is Average Wholesale Price for PROBEN-C?
Summary for PROBEN-C
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Patent Applications: | 10 |
| DailyMed Link: | PROBEN-C at DailyMed |
US Patents and Regulatory Information for PROBEN-C
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | PROBEN-C | colchicine; probenecid | TABLET;ORAL | 085552-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
